Home  >>  News  >>  Emcure Pharmaceuticals Receives SEBI Approval for ₹800 Crore IPO
Emcure Pharmaceuticals Receives SEBI Approval for ₹800 Crore IPO

Emcure Pharmaceuticals Receives SEBI Approval for ₹800 Crore IPO

23 Jun, 2024

Gaurav Poswal

Emcure Pharmaceuticals has received approval from the Securities and Exchange Board of India (SEBI) to launch an initial public offering (IPO) valued at ₹800 crore. The IPO includes a fresh issuance of equity shares worth ₹800 crore and an Offer for Sale (OFS) of 1.36 crore shares by existing shareholders. This move follows an earlier filing in 2021, where the fresh issue component was ₹1,100 crore. The funds raised will primarily be used to repay debt, which will significantly reduce the company's financial liabilities and enhance its growth potential.

Latest News